PERFUSION-UK

作者贡献：提交过程中需列出每位作者的贡献，并在提交稿件中于致谢部分之后加入“作者贡献”标题；提交时填写的信息将在校对阶段显示在“作者贡献”标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

数据可用性：在符合伦理和法律要求的前提下，鼓励作者在相关公共数据仓库共享研究数据，并附上链接数据的数据可用性声明；若无法共享数据，应在声明中说明原因，并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

伦理：即使方法部分已包含伦理批准信息，也须在该标题下写明伦理批准声明；若无需伦理批准，须明确说明。报告涉及人类参与者、人类数据或人类组织的研究时，须写明相关伦理委员会或机构审查委员会批准或豁免批准，并提供审查委员会全名、所属机构及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

开放获取：向本刊投稿或发表无需支付任何费用；彩色图在线版免费以彩色出版，如特别要求印刷版彩色复制，接受稿件后 Sage 会告知相关费用；可通过 Sage Choice 计划及开放获取协议付费选择开放获取，费用视协议而定，可折扣或免费。 模型中文摘要

There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. For specifically requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article. Optional open access publishing is available for a fee via the Sage Choice pr…

同行评审：本刊采用双匿名评审，评审者仅与编辑互动，不公布评审信息；稿件先经初步评估，不符合指南要求的稿件在进入同行评审前退回修改，超出范围或不合适的稿件可能未经同行评审即被拒（desk reject）。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Double anonymised Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

抄袭：期刊和 Sage 严肃对待版权侵犯、抄袭及其他违反出版最佳实践的行为，请阅读 Sage 完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

预印本：本刊接受已在预印本服务器发布的稿件；提交时须在指定字段填写预印本 DOI，并建议在投稿时告知编辑部；同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

临床试验注册：本刊遵循 ICMJE 要求，临床试验须在首个参与者入组时或之前在 WHO 认可的公共试验注册库注册，作为考虑发表的条件；试验注册库名称、URL 及注册号须附在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.